Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › FL › Clermont › NPI 1356326409
Lab

Vista Clinical Diagnostics LLC

Vista Clinical Diagnostics LLC was paid $91K by Medicaid between Mar 2018 and Dec 2023, across 19 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 69% of everything it billed.

33Billing provider infoVISTA CLINICAL DIAGNOSTICS LLC
CLERMONT, FL 34711
33aNPI1356326409assigned 12/13/2005
28Total paid$91K
24GClaims11,862
24DCodes billed19
24AFirst – last monthMar 2018 – Dec 2023
Compared with peers

Next to other Clinical Medical Laboratory providers in Florida

Rank by total paid#109 of 225
Median peer was paid$74K
This provider vs. median1.2×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$5.0K$10K$15K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20181,461$1K
20191,058$483.93
20201,709$3K
20212,038$44K
20222,870$38K
20232,726$4K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 69% 1,302 1,112 $63K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 22% 1,003 926 $20K
P9603 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled 6.8% 2,806 1,797 $6K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,427 1,082 $674.45
36415 Collection of venous blood by venipuncture <1% 2,364 1,590 $450.23
G0471 Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) <1% 842 510 $270.90
80053 Comprehensive metabolic panel <1% 711 568 $221.42
80048 Basic metabolic panel (calcium, ionized) <1% 783 548 $158.57
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 28 28 $31.39
84443 Thyroid stimulating hormone (TSH) <1% 41 40 $23.24
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 59 50 $17.95
87086 Culture, bacterial; quantitative colony count, urine <1% 82 74 $11.41
7 more codes
85610 <1% 58 $9.08
85027 <1% 34 $9.04
83036 Hemoglobin; glycosylated (A1C) <1% 102 $5.78
81001 <1% 82 $3.31
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 0% 14 $0.00
P9604 Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge 0% 82 $0.00
80061 Lipid panel 0% 42 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSANTANA, DAVIAN (PRESIDENT)